ArticleAnnals of laboratory medicine2022

Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma.

Hyun-Young Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.